Global Market Study on COVID-19 Saliva-based Screening: Increasing Ageing Population Susceptible to COVID-19 to Complement Demand Growth Over Short Term

Publish Date: Aug 2021

Report Code: PMR1721A

Publisher: Persistence Market Research

Single User License: $4900

Explore Our Services

Already a member? Login here.

Report Highlights

COVID-19 Saliva-based Screening Market - Scope of Report

The latest publication by Persistence Market Research on the global COVID-19 saliva-based screening market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for growth factors and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the COVID-19 saliva-based screening market.

The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the COVID-19 saliva-based screening market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the COVID-19 saliva-based screening market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the COVID-19 saliva-based screening market offers information divided into five important segments - product, technology, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Saliva collection kits
  • Saliva nucleic acid purification kits
  • Saliva-based Detection kits
  • Rapid test kits
  • PCR-based kits

Technology

  • Saliva collection kits
  • Saliva nucleic acid purification kit
  • Saliva-based Detection kits
  • Rapid test kits
  • PCR-based kits

Application

  • COVID-19 Research
  • COVID-19 Diagnostics

End User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic and Research Institutes
  • Biopharma Companies
  • Long Term Care Facilities
  • Home Care Settings
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for growth factors over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the COVID-19 saliva-based screening market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the COVID-19 saliva-based screening market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the COVID-19 saliva-based screening market more accurate and reliable.

  • Table 1 : Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 2 : Global COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 3 : Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 4 : Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 5 : Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 6 : Global COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Region
  • Table 7 : North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 8 : North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 9 : North America COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 10 : North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 11 : North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 12 : North America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 13 : Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 14 : Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 15 : Latin America COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 16 : Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 17 : Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 18 : Latin America COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 19 : Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 20 : Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 21 : Europe COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 22 : Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 23 : Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 24 : Europe COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 25 : South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 26 : South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 27 : South Asia COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 28 : South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 29 : South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 30 : South Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 31 : East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 32 : East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 33 : East Asia COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 34 : East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 35 : East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 36 : East Asia COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 37 : Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 38 : Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 39 : Oceania COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 40 : Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 41 : Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 42 : Oceania COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Table 43 : MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Country
  • Table 44 : MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Product
  • Table 45 : MEA COVID-19 Saliva-based Screening Market Volume ('000 Units) Analysis and Forecast, 2021–2031, By Product
  • Table 46 : MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Technology
  • Table 47 : MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By Application
  • Table 48 : MEA COVID-19 Saliva-based Screening Market Value (US$ Mn) Analysis and Forecast, 2021–2031, By End User
  • Figure 1 : Global COVID-19 Saliva-based Screening Current and Future Market Volume, 2021-2031 & Y-o-Y Growth Trend Analysis
  • Figure 2 : Global Average Pricing Analysis Benchmark USD (Unit) (2020)
  • Figure 3 : Global COVID-19 Saliva-based Screening Current and Future Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis
  • Figure 4 : COVID-19 Saliva-based Screening Market Absolute $ Opportunity, 2021–2031
  • Figure 5 : Global COVID-19 Saliva-based Screening Market Share Analysis (%) by Product, 2021 & 2031
  • Figure 6 : Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) by Product, 2021–2031
  • Figure 7 : Global COVID-19 Saliva-based Screening Market Attractiveness Analysis, By Product
  • Figure 8 : Global COVID-19 Saliva-based Screening Market Share Analysis (%) by Technology, 2021 & 2031
  • Figure 9 : Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) by Technology, 2021–2030
  • Figure 10 : Global COVID-19 Saliva-based Screening Market Attractiveness Analysis, By Technology
  • Figure 11 : Global COVID-19 Saliva-based Screening Market Share Analysis (%) by Application, 2021 & 2031
  • Figure 12 : Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) by Application, 2021–2030
  • Figure 13 : Global COVID-19 Saliva-based Screening Market Attractiveness Analysis, By Application
  • Figure 14 : Global COVID-19 Saliva-based Screening Market Share Analysis (%) by End User , 2021 & 2031
  • Figure 15 : Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) by End User , 2021–2030
  • Figure 16 : North America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 17 : Global COVID-19 Saliva-based Screening Market Share Analysis (%) by Region, 2021 & 2031
  • Figure 18 : Global COVID-19 Saliva-based Screening Market Y-o-Y Growth (%) by region, 2021–2030
  • Figure 19 : Global COVID-19 Saliva-based Screening Market Attractiveness Analysis, By Region
  • Figure 20 : North America COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 21 : North America COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 22 : North America COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 23 : North America COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 24 : North America COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 25 : North America COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 26 : North America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 27 : North America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 28 : North America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 29 : North America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 30 : Latin America COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 31 : Latin America COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 32 : Latin America COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 33 : Latin America COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 34 : Latin America COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 35 : Latin America COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 36 : Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 37 : Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 38 : Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 39 : Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 40 : Latin America COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 41 : Europe COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 42 : Europe COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 43 : Europe COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 44 : Europe COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 45 : Europe COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 46 : Europe COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 47 : Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 48 : Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 49 : Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 50 : Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 51 : Europe COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 52 : South Asia COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 53 : South Asia COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 54 : South Asia COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 55 : South Asia COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 56 : South Asia COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 57 : South Asia COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 58 : South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 59 : South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 60 : South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 61 : South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 62 : South Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 63 : East Asia COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 64 : East Asia COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 65 : East Asia COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 66 : East Asia COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 67 : East Asia COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 68 : East Asia COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 69 : East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 70 : East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 71 : East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 72 : East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 73 : East Asia COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 74 : Oceania COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 75 : Oceania COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 76 : Oceania COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 77 : Oceania COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 78 : Oceania COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 79 : Oceania COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 80 : Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 81 : Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 82 : Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 83 : Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 84 : Oceania COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 85 : MEA COVID-19 Saliva-based Screening Market Value Share, by Product Type (2021 E)
  • Figure 86 : MEA COVID-19 Saliva-based Screening Market Value Share, by Technology (2021 E)
  • Figure 87 : MEA COVID-19 Saliva-based Screening Market Value Share, by End Users (2021 E)
  • Figure 88 : MEA COVID-19 Saliva-based Screening Market Value Share, by Application (2021 E)
  • Figure 89 : MEA COVID-19 Saliva-based Screening Market Value Share, by Country (2021 E)
  • Figure 90 : MEA COVID-19 Saliva-based Screening Market Forecast & Y-o-Y growth, 2021–2031
  • Figure 91 : MEA COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Product
  • Figure 92 : MEA COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Technology
  • Figure 93 : MEA COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Application
  • Figure 94 : MEA COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By End User
  • Figure 95 : MEA COVID-19 Saliva-based Screening Market Attractiveness Analysis 2021-2031, By Country
  • Figure 96 : U.S. COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 97 : Global Vs. U.S. Growth Comparison
  • Figure 98 : U.S. COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 99 : U.S. COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 100 : U.S. COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 101 : U.S. COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 102 : Canada COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 103 : Global Vs. Canada Growth Comparison
  • Figure 104 : Canada COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 105 : Canada COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 106 : Canada COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 107 : Canada COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 108 : Brazil COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 109 : Global Vs. Brazil Growth Comparison
  • Figure 110 : Brazil COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 111 : Brazil COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 112 : Brazil COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 113 : Brazil COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 114 : Mexico COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 115 : Global Vs. Mexico Growth Comparison
  • Figure 116 : Mexico COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 117 : Mexico COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 118 : Mexico COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 119 : Mexico COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 120 : Argentina COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 121 : Global Vs. Argentina Growth Comparison
  • Figure 122 : Argentina COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 123 : Argentina COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 124 : Argentina COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 125 : Argentina COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 126 : U.K COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 127 : Global Vs. U.K Growth Comparison
  • Figure 128 : U.K COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 129 : U.K COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 130 : U.K COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 131 : U.K COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 132 : Germany COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 133 : Global Vs. Germany Growth Comparison
  • Figure 134 : Germany COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 135 : Germany COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 136 : Germany COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 137 : Germany COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 138 : Italy COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 139 : Global Vs. Italy Growth Comparison
  • Figure 140 : Italy COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 141 : Italy COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 142 : Italy COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 143 : Italy COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 144 : France COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 145 : Global Vs. France Growth Comparison
  • Figure 146 : France COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 147 : France COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 148 : France COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 149 : France COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 150 : Spain COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 151 : Global Vs. Spain Growth Comparison
  • Figure 152 : Spain COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 153 : Spain COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 154 : Spain COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 155 : Spain COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 156 : BENELUX COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 157 : Global Vs. BENELUX Growth Comparison
  • Figure 158 : BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 159 : BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 160 : BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 161 : BENELUX COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 162 : Russia COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 163 : Global Vs. Russia Growth Comparison
  • Figure 164 : Russia COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 165 : Russia COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 166 : Russia COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 167 : Russia COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 168 : China COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 169 : Global Vs. China Growth Comparison
  • Figure 170 : China COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 171 : China COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 172 : China COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 173 : China COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 174 : Japan COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 175 : Global Vs. Japan Growth Comparison
  • Figure 176 : Japan COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 177 : Japan COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 178 : Japan COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 179 : Japan COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 180 : South Korea COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 181 : Global Vs. South Korea Growth Comparison
  • Figure 182 : South Korea COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 183 : South Korea COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 184 : South Korea COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 185 : South Korea COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 186 : India COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 187 : Global Vs. India Growth Comparison
  • Figure 188 : India COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 189 : India COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 190 : India COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 191 : India COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 192 : Thailand COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 193 : Thailand COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 194 : Thailand COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 195 : Thailand COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 196 : Malaysia COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 197 : Global Vs. Malaysia Growth Comparison
  • Figure 198 : Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 199 : Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 200 : Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 201 : Malaysia COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 202 : Indonesia COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 203 : Global Vs. Indonesia Growth Comparison
  • Figure 204 : Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 205 : Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 206 : Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 207 : Indonesia COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 208 : Australia COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 209 : Global Vs. Australia Growth Comparison
  • Figure 210 : Australia COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 211 : Australia COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 212 : Australia COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 213 : Australia COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 214 : New Zealand COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 215 : Global Vs. New Zealand Growth Comparison
  • Figure 216 : New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 217 : New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 218 : New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 219 : New Zealand COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 220 : Turkey COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 221 : Global Vs. Turkey Growth Comparison
  • Figure 222 : Turkey COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 223 : Turkey COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 224 : Turkey COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 225 : Turkey COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 226 : GCC Countries COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 227 : Global Vs. GCC Countries Growth Comparison
  • Figure 228 : GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 229 : GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 230 : GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 231 : GCC Countries COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031
  • Figure 232 : South Africa COVID-19 Saliva-based Screening Market Value Proportion Analysis
  • Figure 233 : Global Vs. South Africa Growth Comparison
  • Figure 234 : South Africa COVID-19 Saliva-based Screening Market Share Analysis (%), by Product in Value, 2021 & 2031
  • Figure 235 : South Africa COVID-19 Saliva-based Screening Market Share Analysis (%), by Technology in Value, 2021 & 2031
  • Figure 236 : South Africa COVID-19 Saliva-based Screening Market Share Analysis (%), by Application in Value, 2021 & 2031
  • Figure 237 : South Africa COVID-19 Saliva-based Screening Market Share Analysis (%), by End User in Value, 2021 & 2031

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Market Study on COVID-19 Saliva-based Screening: Increasing Ageing Population Susceptible to COVID-19 to Complement Demand Growth Over...